PharmEasy
Edit

PharmEasy

https://www.pharmeasy.in/
Last activity: 14.10.2025
Active
Categories: DiagnosticsDrugHealthTechInformationITLocalMedTechOnlineProductService
PharmEasy is one of India’s leading healthcare aggregators and most trusted medicine delivery app - Android /iOS. We help patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. Our aim is to revolutionize and improve the entire supply chain in the pharma sector by completely digitizing the process.

How do we do that?

- Make the industry data driven by providing doctors and patients the most accurate information to make informed decisions
- Make healthcare a universal right by making it quantum's cheaper and accessible
- Construct a feedback loop for pharma companies enabling them to make better medicines to combat diseases like never before
- Eradicate fake medicines which contribute to 30% of drug volume in
India

We’ve tied up with hundreds of offline retailers and authorized phlebotomist to make all genuine medicines available to you, as well as quality diagnostics services.

What makes us stand out from our competitors is we offer FLAT 20% OFF on every medicine order and UP TO 75% discounts on diagnostics tests.

Our persistent efforts have helped us to competently serve over 2 lakh families across India. We’ve touched more than 5 lakh lives and helped them save over INR 20 crores on medical expenses.

Currently, we serve customers in Mumbai, Thane, Navi Mumbai, Pune, Ahmedabad, Jaipur, Delhi, Noida, Gurugram, Kolkata and Bengaluru.

Going further, we aim to expand our geographical presence and penetrate further into existing markets to strengthen our category-leadership position.

For the latest updates, follow us on LinkedIn, Twitter and Instagram.
Likes
111.41K
Followers
152.04K
Website visits
17.4M /mo.
Mentions
161
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Total raised: $2.24B
Valuation: $5B
Founded date: 2015

Investors 11

Show more

Funding Rounds 10

DateSeriesAmountInvestors
04.05.2024-$316M-
23.08.2023-$423.05K-
10.11.2021IPO$842M-
20.10.2021Pre-IPO$350M-
25.06.2021Series C$200MBessemer V...
15.04.2021Series E$350MProsus
29.09.2018Series C$50MEight Road...
26.04.2017Series B$18MBessemer V...
03.04.2017Series B$17M-
-Series D$100M-

Mentions in press and media 161

DateTitleDescription
14.10.2025PharmEasy-Owned Thyrocare’s Q2 Profit Zooms 81% YoY To INR 48 CrSUMMARY On a sequential basis, the company's profit grew 25% from INR 38.3 Cr The company's operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr --> FOL...
10.10.2025Entrepreneurship at Scale: Lessons in Building a House of Brands Ananth Narayanan's three lessons: choose niche markets, think global from day one, and use technology wisely.In today's fast-changing business world, many entrepreneurs find it hard to grow their companies while keeping each brand special. Many D2C startups in India begin with great ideas but struggle to scale up. They face problems like strong co...
27.09.2025From PharmEasy To Curefoods — Indian Startups Raised $377 Mn This WeekSUMMARY Twenty eight startups cumulatively raised $377.4 Mn during September 22-27, making it the highest weekly capital infusion in the Indian startup since June On a weekly basis, this marked an over 19% jump from the $316.6 Mn raised by ...
27.09.2025Quick medicine delivery platform Plazza raises $1.4 million funding led by All In CapitalSynopsis Plazza will use the funds to expand its product range and increase its store footprint in Bengaluru. Currently, it has one store in the city and will add two more this year. While Plazza aims to deliver within 15 to 60 minutes, it ...
16.09.2025PharmEasy To Raise INR 1,700 Cr DebtSUMMARY PharmEasy will raise fresh proceeds via NCD's by pledging the shares of its listed diagnostic company Thyrocare PharmEasy will use the fresh funds to clear the earlier debt which it raised via NCDs, with total outstanding redemption...
08.09.2025PharmEasy FY25 Loss Declines 40% To INR 1,517 CrSUMMARY PharmEasy managed to cut its net losses by 40% to INR 1,516.8 Cr in FY25 from INR 2,522 Cr in the previous fiscal year The operating revenue for FY25 stood at INR 5,872.1 Cr, up 3.6% from INR 5,664.2 Cr recorded in the previous fisc...
08.09.2025CVCs Gain Ground in India with Advantage in Long-Term View for Deeptech In 2024, Bain & Company's India Venture Capital Report finds that CVCs stepped up meaningfully: their deal volumes increased...Corporate Venture Capital (CVC) firms have a disproportionate advantage over traditional VC firms, especially in areas such as deeptech, in terms of long-term mapping, said Adarsh Sekhar, Partner, IBM Ventures. In 2021, IBM committed USD 1 ...
05.09.2025The Future of Generic Medicine Retail in IndiaAhmedabad, Gujarat, India India’s pharmacy and healthcare sector has emerged as one of the most dynamic industries in the world, driven by a growing population, increasing healthcare needs, and rising demand for affordable medicines. With a...
03.09.2025Online pharmacy PlatinumRx raises $6 million in round led by Stellaris Venture PartnersSynopsis Existing investor India Quotient participated in the funding round. The platform, which helps customers find substitute brands of affordable drugs, plans to use the fresh capital to expand operations, add new fulfilment centres and...
01.09.2025India's Tech Surge: Elev8 Closes $160M Fund, Fuels Next-Gen StartupsElev8 Venture Partners concluded its landmark $160 million maiden fund for India's surging tech landscape. The growth-stage vehicle targets high-potential startups in fintech, SaaS, B2B platforms, and consumer brands. Anchor investors inclu...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In